BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 19227387)

  • 1. The metabolic syndrome: a gathering challenge in a time of abundance.
    Bricker LA; Greydanus DE
    Adolesc Med State Art Rev; 2008 Dec; 19(3):475-97, ix. PubMed ID: 19227387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic syndrome: screening, diagnosis, and management.
    Miller EL; Mitchell A
    J Midwifery Womens Health; 2006; 51(3):141-51. PubMed ID: 16647666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiology patient page. The metabolic syndrome.
    Lennie TA
    Circulation; 2006 Oct; 114(15):e528-9. PubMed ID: 17030691
    [No Abstract]   [Full Text] [Related]  

  • 4. Management of the metabolic syndrome.
    Grant RW; Meigs JB
    Panminerva Med; 2005 Dec; 47(4):219-28. PubMed ID: 16489321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Integrated drug therapy of the metabolic syndrome].
    Julius U; Hanefeld M
    Internist (Berl); 1996 Jul; 37(7):722-30. PubMed ID: 8766266
    [No Abstract]   [Full Text] [Related]  

  • 6. Hypertension and dyslipidaemia in obesity and insulin resistance: pathophysiology, impact on atherosclerotic disease and pharmacotherapy.
    Chapman MJ; Sposito AC
    Pharmacol Ther; 2008 Mar; 117(3):354-73. PubMed ID: 18215759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic syndrome: are we at risk?
    Paudel B
    Nepal Med Coll J; 2007 Sep; 9(3):204-11. PubMed ID: 18092442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular disease in the metabolic syndrome: do we need to target the microcirculation to treat large vessel disease?
    Krentz AJ; Clough G; Byrne CD
    J Vasc Res; 2009; 46(6):515-26. PubMed ID: 19571572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The metabolic syndrome as an endocrine disease: is there an effective pharmacotherapeutic strategy optimally targeting the pathogenesis?
    Schindler C
    Ther Adv Cardiovasc Dis; 2007 Oct; 1(1):7-26. PubMed ID: 19124392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A work in progress: the metabolic syndrome.
    Luchsinger JA
    Sci Aging Knowledge Environ; 2006 Jun; 2006(10):pe19. PubMed ID: 16807483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversing the tide of metabolic syndrome.
    Dumas MA
    Nurs Manage; 2003 Jun; 34 Suppl Guide():1-5. PubMed ID: 12867772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Background and treatment of metabolic syndrome: a therapeutic challenge.
    van Zwieten PA; Mancia G
    Semin Cardiothorac Vasc Anesth; 2006 Sep; 10(3):206-14. PubMed ID: 16959752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effective treatments for insulin resistance: trim the fat and douse the fire.
    Evans JL; Youngren JF; Goldfine ID
    Trends Endocrinol Metab; 2004 Nov; 15(9):425-31. PubMed ID: 15519889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac health in women with metabolic syndrome: clinical aspects and pathophysiology.
    Ren J; Kelley RO
    Obesity (Silver Spring); 2009 Jun; 17(6):1114-23. PubMed ID: 19214173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated sympathetic activity may promote insulin resistance syndrome by activating alpha-1 adrenergic receptors on adipocytes.
    McCarty MF
    Med Hypotheses; 2004; 62(5):830-8. PubMed ID: 15082116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
    Resmini E; Minuto F; Colao A; Ferone D
    Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin resistance and the metabolic syndrome-a challenge of the new millennium.
    Hauner H
    Eur J Clin Nutr; 2002 Mar; 56 Suppl 1():S25-9. PubMed ID: 11965519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The metabolic syndrome: definitions, prevalence and management.
    Levesque J; Lamarche B
    J Nutrigenet Nutrigenomics; 2008; 1(3):100-8. PubMed ID: 19776619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pathogenesis of insulin resistance in children: metabolic complications and the roles of diet, exercise and pharmacotherapy in the prevention of type 2 diabetes.
    Artz E; Freemark M
    Pediatr Endocrinol Rev; 2004 Mar; 1(3):296-309. PubMed ID: 16437023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obesity and cardiometabolic syndrome in children.
    Velasquez-Mieyer P; Neira CP; Nieto R; Cowan PA
    Ther Adv Cardiovasc Dis; 2007 Oct; 1(1):61-81. PubMed ID: 19124396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.